NEW YORK, June 21, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will present at the Jefferies Healthcare Conference on Thursday, June 28, 2007 at 1 p.m. Eastern Time. David Bailey, President and CEO, will discuss the Company's business strategy and historical financial performance.

Attendance at the conference is by invitation only. A live audio webcast of STAAR's presentation may be accessed through the Company's website at http://www.staar.com. An archived replay of the presentation will be available after the live presentation and can also be accessed at http://www.staar.com.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. STAAR's ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 40 countries. More than 65,000 ICLs have been sold worldwide. More information is available at http://www.staar.com.

    CONTACT:  Investors                             Media
              EVC Group                             EVC Group
              Jennifer Beugelmans, 646-201-5447     Jen Saunders, 646-201-5431
              Douglas Sherk, 415-896-6820

SOURCE STAAR Surgical Company

investors, Jennifer Beugelmans, +1-646-201-5447, or Douglas Sherk, +1-415-896-6820;
or media, Jen Saunders, +1-646-201-5431, all of EVC Group, for STAAR Surgical Company

http://www.staar.com